Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Applied Biology, Inc. clinical trials
The registry lists 25 studies whose lead sponsor is Applied Biology, Inc.. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 21, 2026.
Keep track of what changes. Save the Applied Biology, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Applied Biology, Inc..
- Applied Biology, Inc.25 studiesSame company
Something wrong?
Focus areas
Conditions Applied Biology, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 25 of 25.
- Clinical Study of DA-020 for the Treatment of Chemotherapy Induced AlopeciaRecruitingNCT07397325Phase 1/2
- Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-GrowthNot yet recruitingNCT06648850Phase 2/3
- Pharmacokinetic Study of DA-020Not yet recruitingNCT07402330Early Phase 1
- Pharmacokinetic Study of Topical PhenylephrineRecruitingNCT07033845Early Phase 1
- Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)Not yet recruitingNCT07166354Phase 1/2
- Clinical Study of DA-007 for the Treatment of Chemotherapy Induced AlopeciaNot yet recruitingNCT06762548Phase 3
- Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)Not yet recruitingNCT06745336Phase 3
- Clinical Study of DA-002 and DA-005 As a Treatment for Hair LossNot yet recruitingNCT06501924Phase 3
- Clinical Study of Probiotic Treatment for Androgenetic AlopeciaWithdrawnNCT06484881Phase 3
- Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002CompletedNCT06095739Not applicable
- In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease SeverityWithdrawnNCT04368897
- Comparison of JW-100 and EUCRISA for the Treatment of Atopic DermatitisWithdrawnNCT05016284Phase 3
- Treatment for Post Acute COVID-19 SyndromeStatus unknownNCT05507372Not applicable
- Proxalutamide Treatment for COVID-19 Patients in Intensive Care UnitWithdrawnNCT04853927Phase 3
- Proxalutamide Treatment for COVID-19 Female OutpatientsWithdrawnNCT04853134Phase 3
- HC-1119 Adjuvant Treatment for Hospitalized COVID-19 PatientsStatus unknownNCT04986176Phase 3
- Anti-Androgen Treatment for COVID-19CompletedNCT04446429Not applicable
- HairDx Analytical Validation StudyWithdrawnNCT04379583
- Proxalutamide Treatment for Hospitalized COVID-19 PatientsCompletedNCT04728802Phase 3
- Study to Investigate the Effect of AB-101 in Breast Cancer SurvivorsCompletedNCT03592121Early Phase 1
- Minoxidil Response Testing in Females With Female Pattern Hair LossCompletedNCT02206802
- Minoxidil Response Testing in Males With Androgenetic AlopeciaCompletedNCT02198261
- Photocil (Topical) for the Treatment of Atopic DermatitisCompletedNCT01992172Not applicable
- Photocil (Topical) for the Treatment of Psoriasis VulgarisCompletedNCT01916629Not applicable
- Photocil (Topical) for the Treatment of VitiligoCompletedNCT01992185Not applicable